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ABSTRACT
In Positron Emission Tomography (PET) imaging, patient motion due to respiration
can lead to artefacts and blurring, in addition to quantiﬁcation errors. The integration
of PET imaging with Magnetic Resonance (MR) imaging in PET/MR scanners provides
spatially aligned complementary clinical information, and allows the use of high spatial
resolution and high contrast MR images to monitor and correct motion-corrupted PET
data. We test our PET respiratory motion correction methodology based on a joint PET-
MR motion model, on a patient cohort, showing it can improve lesion detectability and
quantitation, and reduce image artefacts.
Methods: We apply our motion correction methodology on 42 clinical PET-MR
patient datasets, using multiple tracers and multiple organ locations, containing 162
PET-avid lesions. Quantitative changes are calculated using Standardised Uptake Value
(SUV) changes in avid lesions. Lesion detectability changes are explored with a study
where two radiologists identify lesions, providing conﬁdence levels, in uncorrected and
motion-corrected images.
Results: Mean increases of 12.4% for SUVpeak and 17.6% for SUVmax following
motion correction were found. In the detectability study, an increase in conﬁdence scores
for detecting avid lesions is shown, with a mean score of 2.67 rising to 3.01 (out of 4) after
motion correction, and a detection rate of 74% rising to 84%. Of 162 conﬁrmed lesions,
49 lesions showed an increase in all three metrics SUVpeak, SUVmax and combined reader
conﬁdence scores, whilst only two lesions showed a decrease. We also present clinical
case studies, demonstrating the eﬀect respiratory motion correction of PET data can
have on patient management, with increased numbers of lesions detected, improved
lesion sharpness and localisation, as well as reduced attenuation-based artefacts.
Conclusion: We demonstrate signiﬁcant improvements in quantiﬁcation and detec-
tion of PET-avid lesions, with speciﬁc case study examples showing where motion cor-
rection has the potential to have an eﬀect on patient diagnosis or care.
Keywords Motion Correction · PET/MR · Lesion Detection · Lesion Quantiﬁcation
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INTRODUCTION
Due to long acquisition duration (typically 3-15 minutes per bed position), motion
during PET acquisition may lead to blurring in resulting images and errors in
quantiﬁcation (1,2 ). The already limited spatial resolution of PET, around 4.5 mm
full width half maximum, is eﬀectively reduced when motion occurs during
acquisition. In oncology, tumours in the upper abdomen and thorax are particularly
adversely aﬀected by respiratory motion, due to a movement of the diaphragm of
around 20 mm on average in one breathing cycle (3 ). Lesions at anatomy boundaries
such as between the liver and lung can also be mispositioned on images when
compared to the anatomical reference MR or CT image. Furthermore, quantiﬁcation is
aﬀected as moving lesions show an apparent increase in size and decrease in uptake as
the lesion appears smeared. Motion may also cause problems with attenuation
correction, where a static attenuation map does not correlate spatially with the PET
emission data, due to moving anatomy (4 ).
PET respiratory motion correction can be achieved by gating (splitting data into
respiratory states), reconstructing separate images and registering to a common
respiratory state (2,5,6 ). This technique requires a good signal-to-noise ratio in each
gated image for accurate registration results. This becomes diﬃcult with pressures of
reducing scan time and lowering patient dose, leading to low count statistics and lower
signal-to-noise ratio in each gate. The recent advent of PET/MR scanners allows
exploitation of modality simultaneity by using high spatial resolution and high
contrast MR images to estimate respiratory motion and correct PET data, without
additional radiation exposure, with MR tagging (7,8 ), or by acquiring quick
’motion-capturing’ 2D images (9 ) or low resolution 3D images (10 ).
Although current methods for respiratory motion correction in PET/MR show an
improvement in PET image quality, all require a change to the otherwise intended
PET/MR protocol to be able to collect the respiratory signal and/or MR-derived motion
model in a clinical setting. Many methods use external monitoring device to obtain a
respiratory signal, which requires time for set-up and readjustment, and can fail due to
mispositioning, patient movement, poor calibration, or signal drift and clipping. Some
methods also require alteration to MR sequences which need to be set up in advance
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of the scan, can create artefacts in MR images near the diaphragm, and may increase 
scan time.
In recent work, we demonstrated the capability of a joint PET-MR respiratory 
motion model built using data from a 1 minute dynamic MR sequence, and with no 
external hardware required (11 ). The methodology addressed many of the limitations 
found with the discrete binning method used in our previous work (12 ). In this 
current work, we perform a pilot analysis to test the methodology on a larger patient 
cohort, by examining change in SUV metrics on attenuation corrected PET 
reconstructions and by performing a lesion detectability study. In this study, two 
readers examine each uncorrected and motion-corrected image and mark suspected 
lesions with a conﬁdence score, so the true-positive (TP) and false-positive (FP) 
detection rate can be calculated, as well as changes in conﬁdence scores between 
uncorrected and motion-corrected images. Finally, we present a number of illustrative 
examples, to demonstrate how respiratory motion correction may have the potential to 
aﬀect clinical patient management, for example, on patient staging, diagnosis and 
surgical planning.
MATERIALS AND METHODS
Respiratory Motion Correction via Joint PET-MR Motion Model
In our recent work, a methodology for a joint PET-MR motion model was described, 
using one minute of simultaneously acquired PET and MR data to provide a 
respiratory motion model that captured inter-cycle and intra-cycle breathing 
variations (11 ). The continuous nature of the model allows interpolation and 
extrapolation at any respiratory signal value, meaning 100% of PET data is used in 
the reconstruction, and deformation ﬁelds are estimated even at extreme values such 
as at deep inhale for the MRAC sequence. All slices of the free-breathing MR 
acquisition are used, with an optimisation scheme to form the model that is robust to 
registration errors at single slices. MR and PET data were also aligned temporally by 
including a time-shift in the optimisation while taking the diﬀerent hardware clock-rates 
into account. The motion model links one or more surrogate measures of respiratory 
motion to the tissue deformation. In our previous work, we found the best
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performance was achieved when using the PET-derived respiratory signal and it’s 
gradient in a 2-surrogate model. The model used a linear ﬁt to relate the surrogates to the 
deformations. This scheme is used in the current work, on a larger patient data set, to 
estimate deformations throughout the PET scans.
Study Design
The UK Health Research Agency approved this retrospective study and the requirement 
to obtain informed consent was waived. All data were acquired using an integrated 3T 
PET/MR system (Biograph mMR, Siemens Healthcare).
Data were retrospectively analysed from 42 patients whom had undertaken 
PET/MR scans between February 2014 and November 2015, selected based on clinical 
information suggesting possible avid regions in the thorax or abdomen. Tracers used 
were 18F-FDG (24 patients) and 68Ga-DOTATATE (18 patients). The patient cohort 
consisted of 18 women and 24 men, with a mean patient age of 61.9 years (range,
36-85 years).
The PET/MR imaging protocols included an additional breath-hold Dixon scan
and a one minute free-breathing dynamic MR sequence (2D multi-slice gradient echo
(1 min), sagittal slices at 9 slice locations, covering the thorax and abdomen (including
lungs, liver, pancreas etc.) repeated 60 times. Scan parameters: slice thickness 10mm,
gap between slice centres 25 mm, repetition time 5.1 ms, echo time 2.5 ms, ﬂip angle 10◦,
pixel bandwidth 965 Hz, matrix size 192 x 144, FOV 262 x 349 mm, in-plane resolution
1.8 x 1.8 mm2, IPAT 3, acquisition time per image 0.3 s), used for quality monitoring
related to breathing and MRAC. Data from the one minute MR sequence was used here
to build the patient-speciﬁc motion model. Four consecutive minutes of PET list-mode
data were used for the PET reconstructions presented here, with the mean time interval
from radiotracer injection to this PET data being acquired being 1 hour 39 minutes ±
33 minutes. The four minutes of PET data used here include the one minute of cine
MRI acquisition and the preceding three minutes
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Data Processing
A motion-compensated reconstruction of four minutes from the PET acquisition was
carried out using deformation ﬁelds estimated by the 2-surrogate linear model, with
PET data gated before reconstruction using the patient-speciﬁc scheme outlined in
(11 ). For motion-corrected reconstructions, the attenuation μ-map was warped to each
gate with deformation ﬁelds estimated by the motion model, using the values of the
surrogate signal during the MRAC sequence acquisition. For uncorrected
reconstructions, the acquired static μ-map was used. An ordered-subset expectation
maximization reconstruction algorithm was used, with 21 subsets, 3 iterations, and
4-mm gaussian post-ﬁltering, with randoms and scatter correction.
PET data processing (unlisting, reconstruction etc.) was carried out with STIR 
(Software for Tomographic Image Reconstruction) (13 ). All other analysis was 
performed with Matlab (Mathworks, Inc.) and MIRT (Medical Image Registration 
Toolbox) (14 ) was used in Matlab for registration.
Analysis
Lesion Detectability Study
The eﬀect of motion correction on lesion detectability and localisation was assessed with 
a lesion detection study. Two accredited radiologists viewed the uncorrected and motion-
corrected PET images for each patient data set on their own, without the beneﬁt of any 
structural MR images. The viewing was done individually, and blinded. Images were read 
in two sets, with the uncorrected and motion-corrected images for each patient split 
between the two sets randomly, and with at least a two week interval between reads of 
each set to minimise recall bias. Each reader was free to scroll through slices and adjust 
colour scales. The readers were instructed to detect the presence of focal areas of tracer 
uptake higher than background activity, and which had the potential to represent 
pathological change and inﬂuence clinical decision. They were asked to mark suspected 
lesions on each image, with a four-point conﬁdence score χ. This was deﬁned as the 
presence of a lesion at each location being either:
– χ=1. questionable (<50% likely)
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– χ=2. possible (50-75% likely)
– χ=3. probable (75-95% likely)
– χ=4. deﬁnite (>95% likely)
Scores provided by reader 1 and reader 2 are referred to as χ1 and χ2 respectively. The 
perceived anatomical locations of the lesions on the uncorrected and motion-corrected 
PET images were also documented with each mark by each reader.
For the purpose of this study, the reference standard used to deﬁne the presence and 
locations of lesions was a consensus read by the radiologists, using combined reading of all 
imaging studies, including original uncorrected PET, MR component of the hybrid PET/
MR study, contemporaneous formal MR and CT and all follow-up imaging (CT, MR, 
PET), where available. Lesions marked by the two readers in uncorrected and motion-
corrected images were matched visually to the reference read. Each marked lesion that 
matched a lesion in the reference was deﬁned as a true-positive (TP), and any lesion in 
the reference that was not marked by the reader was deﬁned as a false-negative (FN) and 
given a score of 0. Each marked lesion that did not match a lesion in the reference was 
deﬁned as a false-positive (FP).
For all lesions in both the TP and FP sets, change in conﬁdence rating for each 
lesion, Δχ is deﬁned as the χ score for the motion-corrected image minus the χ score 
for the uncorrected image. For readers 1 and 2 these are referred to as Δχ1 and Δχ2 
respectively. An increase in these values represents an increase in detection conﬁdence, 
and a decrease represents a decrease in detection conﬁdence after motion correction.
SUV Analysis
Change in two SUV metrics for lesions were assessed; ΔSUVpeak, deﬁned as the 
maximum average activity concentration within a 12 mm diameter sphere inside a 
manually deﬁned region of interest (15 ), and ΔSUVmax, deﬁned as the maximum 
voxel SUV value inside the region of interest.
Statistical Analysis
Signiﬁcance of diﬀerences in lesion detection conﬁdence scores between uncorrected and 
motion-corrected images was made with the Wilcoxon signed rank test. For SUV metrics 
of lesions a paired sample t-test test was used.
by UCL Library Services on March 15, 2018. For personal use only. jnm.snmjournals.org Downloaded from 
8 Manber et al
RESULTS
In total, there were 162 PET-positive lesions (74 68Ga-DOTATATE, 88 18F-FDG) in the 
patient data (identiﬁed in the radiologist reference read), in the form of liver, pancreas, 
kidney, bowel, rib and shoulder lesions, as well as an assortment of nodes and areas of 
benign uptake, spread across 32 patients. We use the term ’lesion’ to describe any of these 
marked areas of focal tracer uptake. 10 patients had no identiﬁable or lesions. We use the 
term ’lesion’ to describe any of these marked areas of focal tracer uptake. These are 
summarised in Table 1.
Of 162 reference lesions, 72 were also conﬁrmed to be present on MR, seven on CT, 
and 62 on both MR and CT. 21 lesions were conﬁrmed either from PET follow-up, 
or from PET only considering patient history and information. A quantitative analysis 
summary is provided in Table 2.
Lesion Detectability
The TP rate, or sensitivity, for uncorrected and motion-corrected images was 85% and 
95% respectively for reader 1, and 62% and 73% respectively for reader 2. On average, 
between the two readers over all 162 lesions, the TP rate was 74% (79% Ga only, 69%
18F-FDG only) in the uncorrected images, rising to 84% (89% 68Ga-DOTATATE only, 
80% 18F-FDG only) in the motion-corrected images.
Fig.1 shows Δχ scores for TP results, with positive change showing an increase in 
lesion detectability. Figure 1A shows Δχ distribution for all 162 lesions, for each reader 
separately. Considering the average of Δχ1 and Δχ2 over all 162 lesions, 8% (13 lesions) 
showed a decrease, 69% (112 lesions) showed no change, and 23% (37 lesions) showed an 
increase in conﬁdence ratings. Between the two readers, there was a signiﬁcant increase in 
mean detection conﬁdence score for TP results, from 2.67 (2.92 68Ga-DOTATATE, 2.46 
18F-FDG) in the uncorrected images, to 3.01 (3.21 68Ga-DOTATATE, 2.85 18F-FDG) in 
the motion-corrected images (p<0.0001).
Fig. 1C shows the sum of detection scores Δχ1+2 for each lesion. Overall, 11% (18 
lesions) showed a decrease (range -4:-1), 53% (86 lesions) showed no change, and 36%
(58 lesions) showed an increase (range +1:+8).
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There was a signiﬁcant increase in summed detection conﬁdence scores, Δχ1+2 from 
the uncorrected images to the motion-corrected images, for all TP lesions (p<0.0001).
We aimed to reduce the intrinsic intra- and inter-observer variability of the scoring 
test by examining score changes where Δχ1 and Δχ2 are either both positive or both 
negative; where the two readers are in agreement as to whether a lesion has increased 
or decreased in detectability. There were 14 lesions where this was the case, with one 
lesion showing negative change for both readers (range -1:-2), and 13 lesions showing 
positive change for both readers (range +1:+4). For four of these lesions, conﬁdence 
scores changed from 0 in the uncorrected images for both readers, i.e. lesions which 
were invisible to both readers in uncorrected images, then detectable to some degree in 
the motion-corrected images to both readers.
The total number of FP detections, combining results from both readers, was 30 (7 
68Ga-DOTATATE, 23 18F-FDG) in uncorrected images and 21 (8 68Ga-DOTATATE, 13 
18F-FDG) in motion-corrected images. Overall, 27 lesions showed a decrease, three 
lesions showed no change, and 16 lesions showed an increase in conﬁdence ratings, for 
marked areas assumed to not be true lesions from the reference read.
SUV Analysis
Over all 162 reference lesions, there was a signiﬁcant increase in both SUVpeak 
(p<0.0001) and SUVmax (p<0.002), with a mean increase in SUVpeak of 12.4% (12.6%
68Ga-DOTATATE, 12.2% 18F-FDG), and a mean increase in SUVmax of 17.6%(17.2% 
68Ga-DOTATATE, 17.9% 18F-FDG), via motion-correction.
Fig. 2 shows ΔSUVpeak and ΔSUVmax for all lesions. Of all lesions, 14% (22 lesions) 
showed a decrease, and 86% (140 lesions) showed an increase in SUVpeak, whilst 17%
(27 lesions) showed a decrease, and 83% (135 lesions) showed an increase in SUVmax.
Deﬁning ’considerable change’ as only those with a magnitude of change greater 
than 5% for both ΔSUVpeak and ΔSUVmax; 3% (ﬁve lesions) showed considerable 
decrease, 43% (69 lesions) showed inconsiderable change, and 54% (88 lesions) showed 
considerable increase. The ﬁve lesions that showed considerable decrease were a lung 
node, lung lesion, rib lesion and two bowel lesions.
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Cross-study Correlation
Overall, considering the three metrics of ΔSUVpeak, ΔSUVmax, and Δχ1+2 for the 162
reference lesions, two lesions showed a decrease in all metrics and 49 showed an increase
in all metrics. Those that showed negative change were a mediastinal lymph node and
a bowel lesion.
Clinical Case Studies
We present a number of case study examples to show the eﬀects of motion correction on
PET images, considering potential to aﬀect clinical patient management. Clinical MR
images presented were either acquired at exhale breath-hold or triggered, with data only
collected at the exhale position. Uncorrected and motion-corrected images are displayed
with the same colour scale for each case study.
Case Study 1: New Lesions Detected with MR conﬁrmation
Case study 1 is a 68Ga-DOTATATE scan of a patient (age 70-80) whom had recurrent
neuroendocrine liver metastases post partial hepatectomy. A contemporaneous MRI
showed at least two suspicious lesions in the remnant liver and several smaller concerning
deposits.
In total, change in detection scores for three very small lesions was Δχ1+2 =
[+1,+1,+1], with six of the total reads (3 lesions × 2 readers) providing three newly
detected lesions in the motion-corrected images. All three were found to be present in
the MR images during the consensus reference read. Fig. 3A shows one of the newly
detected lesions in uncorrected and motion-corrected images, with the lesion contrast
appearing much greater in the motion-corrected image. SUV results verify these
results, with increases in SUV metrics for the three lesions (Fig. 3B).
At least three lesions demonstrate DOTATATE avidity, suggesting metastatic
neuroendocrine lesions. This information would inﬂuence decision regarding choice of
treatment, which may be drug treatment (e.g. octreotide analogue), percutaneous
ablation or resection.
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Case Study 2: New Lesions Detected with PET Follow-up conﬁrmation
Case study 2 is a 68Ga-DOTATATE scan of a patient (age 40-50) known to have multiple
endocrine neoplasia syndrome type 1 and known pancreatic lesions. A PET/MR scan
was requested to assess lesion uptake and determine possible surgical approach.
Although the lesions were not veriﬁed in the MR images available, six lesions were
conﬁrmed as present in the reference read due to visibility in a follow-up scan carried
out one year later (Fig. 4).
The increased number of detected lesions in the baseline scan is crucial. Accurate
mapping of the number and location of tumours in the pancreas is critical for the
evaluation of the risk vs beneﬁt balance of surgical intervention, and to plan for the
operation if surgery is pursued. The larger the extent of pancreatectomy, the more
complex the surgery would be and the risk of subsequent diabetes as a complication.
Case Study 3: Lesion Localisation Change
Case study 3 is an 18F-FDG scan for a patient (age 40-50) with known liver metastases
found in a previously acquired CT scan.
Lesion localisation for one reader changed from lung to liver following motion
correction. The reference read for this patient showed eight lesions, with all conﬁrmed
in the liver on the MR. This change in location is demonstrated in Fig. 5A, showing a
PET maximum intensity projection of the uncorrected image. The location of the two
lesions at the lung/liver interface is unclear in both the non-attenuation corrected and
attenuation corrected images, however in the motion-corrected image, it is clear that
the lesions are located in the liver. The fused PET/MR images show better spatial
alignment of the PET and MR images in the motion-corrected case in Fig. 5B.
This large change in location is due to the MRAC being inadvertently acquired at
deep exhale, and this is being corrected for in the method. The alignment of the MRAC
meant large changes in ΔSUVpeak (+142% and +366%), for the lesions which appeared
to move from the lung in the uncorrected image to the liver in the motion-corrected
image.
The correction of lesion localisation through motion correction is important for
staging and treatment planning. Involvement of more organs by metastases could
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potentially changes disease stage, inﬂuence treatment decisions and infer a diﬀerent
prognosis.
Case Study 4: Intra-Lesion Activity Distribution Change
Case study 4 is a 68Ga-DOTATATE scan (age 60-70). In this patient, detectability
conﬁdence scores showed either no change or a slight increase in all 11 lesions identiﬁed
in the reference read. The shape of the activity distribution in three of these lesions was
changed due to motion correction (Fig. 6). These are nectrotic lesions with uptake on
the outer edge of the lesion.
Although lesion detection and localisation has not been signiﬁcantly changed, the
uptake distribution within lesions could be of clinical importance. For example, change
in intra-lesional uptake distribution may inﬂuence the perceived optimal site for PET
directed biopsy in some patients, or in PET guided radiotherapy modulation in others.
Case Study 5: Artefact Reduction
Case study 5 is a 68Ga-DOTATATE scan (age 50-60). The artefact in the uncorrected
image due to a mis-aligned attenuation map has been corrected in the motion-corrected
image (Fig. 7). In the PET images it is clear that the banana artefact at the top of the
liver has been removed and the shape of high uptake in the stomach has been restored
to match the shape of the stomach as seen in the MR. The motion-corrected PET image
now spatially aligns better with the MR.
DISCUSSION
This work has provided a pilot analysis for a clinical validation of our joint PET-MR
model-based motion correction method. Signiﬁcant increases in all tested metrics have
been shown in reference lesions, with mean increases of 12.4% and 17.6% in SUVpeak and
SUVmax respectively, in 162 PET-avid lesions. We also showed an increase in conﬁdence
scores of readers detecting avid lesions, with a mean score of 2.67 rising to 3.01 through
motion correction, and a TP rate of 74% rising to 84%. We found only two lesions that
showed a decrease in all three metrics SUVpeak, SUVmax and Δχ1+2, whilst 49 lesions
showed an increase in all metrics.
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A number of clinical examples were presented to understand the range of positive
eﬀects that respiratory motion with our methodology correction can have, including
newly detected lesions, increased lesion sharpness and detectability, artefact reduction,
and better lesion localisation and intra-lesion activity distribution.
In the SUV analysis, (Fig. 2), the apparent outliers arise from good results, where the
large increases in lesion SUVpeak and SUVmax are due to attenuation map misalignment
being corrected through motion correction. The only ﬁve lesions that show considerable
(more than 5%) decrease in SUV measurements could be due to the lesion locations.
Two of these (including the largest decrease of 25%) were lesions located in the bowel,
which is an area in which the motion model cannot predict motion due to bowel motion
being sporadic and unrelated to respiration. Another was located on a rib, which could
have suﬀered from poor deformation estimation due to the lack of sliding motion in the
registration scheme, and the other two were in the lung of one patient with a very large
lung mass, potentially causing unpredictable breathing patterns.
For the lesion detectability study, when considering combined lesion conﬁdence
scores from both readers, 11% of lesions showed a decrease and 36% showed an
increase in detectability, with a much smaller range in the decrease set (-4:-1 vs.
+1:+8).
One limitation of the detectability study was intra- and inter- observer variability in 
interpretation of imaging studies. The inter-reader variability observed here was higher 
than might be expected for a PET study focussing on a speciﬁc clinical context. However, 
the current study used multiple cohorts of patients and diseases. In addition, the PET 
images were initially read in isolation to assess detectability, without clinical patient 
information or structural images from MR/CT.. We attempted to overcome this by 
analysing results from both readers together. For example, when looking at only results 
where Δχ was either positive or negative for both readers in all reference lesions, 13 
lesions showed an increase in detectability and only one showed a decrease. However, this 
single lesion had a higher SUVpeak and SUVmax in the motion-corrected image than the 
uncorrected image, suggesting that the negative Δχ was also due to human error.
A recommended approach to test lesion detectability is Free-response Receiver 
Operating Characteristic analysis (16 ). We did not carry out this analysis due to a
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lack of a consistent reference standard and no deﬁnite method to identify
false-positives. In the literature, PET-based detection studies revolving around testing
diﬀerent reconstruction methods (17 ), diﬀerent acquisition times (18 ), motion
correction (19 ), or time-of-ﬂight impact (20 ), use phantom or simulated PET data,
where a ground truth is known. The information that PET provides is unique in that
it is portraying tracer uptake, unique to the modality. For example a lesion may
appear avid in a PET image but this does not mean it will necessarily be visible in an
MR or CT image.
The lack of a deﬁnite way to deﬁne false-positives (a PET avid lesion may not appear
in MR or CT) applies to the results presented in this work for the FP rate, where 30
lesions were detected in the uncorrected images and 21 in the motion-corrected images,
from 84 data sets (42 patients × 2 readers). These are marked as false-positives due to
the lack of evidence in the patient information or other modality, but in reality some of
these may be real lesions.
We consider the work in this a pilot analysis. With streamlined pipeline and
enhanced data processing eﬃciency, this can be adopted into routine practice, which
in turn would provide the substrate needed for wider clinical validation.
CONCLUSION
We have demonstrated signiﬁcant improvements in quantiﬁcation and detection of PET-
avid lesions in multiple tracers and multiple organ locations, with speciﬁc case study
examples showing where motion-correction has the potential to have an eﬀect on patient
diagnosis or care.
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FIGURE 1: Change in conﬁdence scores χ between uncorrected and motion-corrected
images for true-positive (TP) lesions, for reader 1 only and reader 2 only (A), and for
reader 1 and reader 2 score sum for each lesion (B). White bars represent the number of
lesions with speciﬁc score changes. Hatched bars represent the total number of lesions
with negative or positive score changes, where positive change is ’good’ - TP lesions are
more detectable after motion correction.
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FIGURE 2: Histogram of all 162 reference lesions for metrics, ΔSUVpeak (A), and
ΔSUVmax (B).
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FIGURE 3: Case study 1. Lesion 1, axial slices of uncorrected (U) and motion-corrected
(MC) PET images, and fused with T1 Dixon VIBE MR.
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FIGURE 4: Case study 2. PET maximum intensity projection (MIP) image showing 3
pancreas lesions and axial views of uncorrected (U) and motion-corrected (MC) PET
images in both the baseline and follow-up PET scans, and fused with T1 Dixon VIBE
MR.
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FIGURE 5: Case study 3. Maximum intensity projection (MIP) images for non-
attenuation-corrected non-motion-corrected image (NAC U), attenuation-corrected
non-motion-corrected image (U), and attenuation-corrected motion-corrected image
(MC) (A). Axial PET slice with three lesions which wrongly appear in the lung in
the uncorrected image (U) and correctly appear in the liver in the motion-corrected
image (MC), and fused with T2 HASTE MR (B).
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FIGURE 6: Case study 4. Coronal and axial slices of uncorrected (U) and motion-
corrected (MC) PET images, and fused with T1 VIBE SPAIR MR, showing change in
shape of uptake in necrotic lesion.
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FIGURE 7: Case study 5. Coronal slice of uncorrected (U) and motion-corrected (MC)
PET images, and fused with T1 VIBE MR, showing a reduction in attenuation mis-
alignment artefacts.
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PET +ve Hot Spot Number
Liver lesion 71
Pancreas lesion 22
Lung lesion 27
Abdomen node 6
Thorax node 29
Other (kidney, bowel etc.) 7
Total 162
TABLE 1: Lesion summary in patient cohort.
All Images (42 patients, 162 lesions)
Metric Uncorrected Motion-corrected Paired Signiﬁcance
SUVpeak 17.6±18.0 19.5±20.1 p<0.0001 (t-test)
SUVmax 22.7±22.6 26.6±29.9 p<0.002 (t-test)
Detection score χ 2.67 ± 1.50 3.01 ± 1.29 p<0.0001 (Wilcoxon)
TP (true-positive) rate 74% 84% N/A
FP (false-positive) 30 lesions 21 lesions N/A
TABLE 2: Quantitative results summary for all images. SUV metrics are means across
all reference lesions. Detection scores and TP numbers are means across both readers.
FP numbers are from 84 data sets (42 patients × 2 readers). Statistical signiﬁcance is
based on paired scores from uncorrected and motion-corrected data sets.
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